Piramal buys Cipla's i-pill for Rs 95 crore

25 Mar 2010 Evaluate

Piramal Healthcare bought Cipla’s oral contraceptive brand, i-pill, for Rs 95 crore, to achieve its target of trebling its over-the-counter (OTC) drug business in three years. i-pill is an emergency contraceptive brand, that recorded Rs 31 crore sales last year, and competes with Mankind Pharma’s Unwanted 72, in a fast-growing, Rs 100-crore Indian market.

The all-cash acquisition of the brand is part of Piramal’s efforts to grow its OTC drug business in India. Cipla sold the brand because it wishes to focus on its prescription products. Servicing just one OTC brand is not a good idea. It needs a large support system, which is better used by someone who has a basket of OTC products. Piramal will scout for more such acquisition in the OTC segment.

crackcrack

Piramal Enterprises Share Price

981.35 -41.65 (-4.07%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 9111.20
Shriram Finance 655.65
Aditya Birla Capital 195.90
SBI Cards AndPayment 866.05
Mah & Mah Finl. Serv 264.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...